Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 7.90 | 0.10 | 27.07 |
| 6M | 8.57 | 1.34 | 116.47 |
| 1Y | 19.53 | 5.08 | 232.82 |
| 3Y | 0.00 | 14.66 | 384.98 |
HDFC Pharma and Healthcare Fund Growth managed by HDFC Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹1,977 Crore. The fund benchmarks its performance against the BSE Healthcare while maintaining an expense ratio of 2.1. Under the expert guidance of Nikhil Mathur ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Mr. Nikhil Mathur holds PGDM - IMT, Ghaziabad, B.E. (Civil) - PEC, Chandigarh, CFA (USA) level 3 cleared. He has over 7 years of experience in equity research and 2 years in financial advisory.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| This FundSamco Special Opportunities Fund Growth | 0 | 126.17 CR | 2.41 |
| This FundAxis Services Opportunities Fund Growth | 0 | 1442.83 CR | 2.13 |
| This FundHDFC Pharma and Healthcare Fund Growth | 0 | 1976.86 CR | 2.1 |
| This FundICICI Prudential PSU Equity Fund Growth | 2 | 1798.21 CR | 2.1 |
| This FundNippon India Taiwan Equity Fund Growth | 3 | 1138.67 CR | 2.36 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundSamco Special Opportunities Fund Growth | 1.3819 | 0 |
| This FundAxis Services Opportunities Fund Growth | 0 | 0 |
| This FundHDFC Pharma and Healthcare Fund Growth | 19.5266 | 0 |
| This FundICICI Prudential PSU Equity Fund Growth | 9.5856 | 97.7477 |
| This FundNippon India Taiwan Equity Fund Growth | 228.2536 | 365.2442 |